MLSS Logo

Milestone Scientific Inc (MLSS) Stock Forecast & Price Prediction

Live MLSS Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Instruments & Supplies

$1.24

-0.03 (-2.36%)

12 Month Price Forecast For MLSS

$1.24
Current Price
$98.92M
Market Cap
2 Ratings
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to MLSS Price Forecasts

+141.9%
To High Target of $3.00
+71.4%
To Median Target of $2.13
+0.8%
To Low Target of $1.25

MLSS Price Momentum

+3.3%
1 Week Change
+5.1%
1 Month Change
+93.8%
1 Year Change
+29.2%
Year-to-Date Change
-10.8%
From 52W High of $1.39
+129.6%
From 52W Low of $0.54

๐Ÿค” Considering Milestone Scientific (MLSS)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 10, 2025 8:24 PM UTC

MLSS Analyst Ratings & Price Targets

Based on our analysis of 1 Wall Street analysts, MLSS has a consensus that is bullish. The median price target is $2.13, with forecasts ranging from $1.25 to $3.00. Currently, there are 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.

With MLSS currently trading at $1.24, the median price forecast suggests a 71.4% upside. The most optimistic forecast comes from at , projecting a 141.9% upside, while Bruce Jackson at Benchmark provides the most conservative target, suggesting a 0.8% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

MLSS Analyst Consensus

2
Buy
0
Hold
0
Sell

MLSS Price Target Range

Low
$1.25
Average
$2.13
High
$3.00
Current: $1.24

Latest MLSS Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for MLSS.

Date Firm Analyst Rating Change Price Target
Nov 20, 2024 Benchmark Bruce Jackson Speculative Buy Reiterates $1.25
Oct 10, 2024 Benchmark Bruce Jackson Speculative Buy Initiates $1.25

Stocks Similar to Milestone Scientific Inc

The following stocks are similar to Milestone Scientific based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Milestone Scientific Inc (MLSS) Financial Data

Milestone Scientific Inc has a market capitalization of $98.92M with a P/E ratio of -12.2x. The company generates $8.42M in trailing twelve-month revenue with a -54.9% profit margin.

Revenue growth is -36.3% quarter-over-quarter, while maintaining an operating margin of -96.0% and return on equity of -59.4%.

Valuation Metrics

Market Cap $98.92M
Enterprise Value $44.83M
P/E Ratio -12.2x
PEG Ratio -31.8x
Price/Sales 11.7x

Growth & Margins

Revenue Growth (YoY) -36.3%
Gross Margin +73.0%
Operating Margin -96.0%
Net Margin -54.9%
EPS Growth +22.1%

Financial Health

Cash/Price Ratio +6.0%
Current Ratio 3.0x
Debt/Equity 4.3x
ROE -59.4%
ROA -36.3%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Milestone Scientific Inc logo

Milestone Scientific Inc (MLSS) Company Overview

About Milestone Scientific Inc

What They Do

Develops advanced injection technologies for healthcare.

Business Model

Milestone Scientific Inc. generates revenue through the design, development, and commercialization of specialized medical devices and technologies, particularly in the dental and medical sectors. Its product offerings, such as the CompuDent and CompuFlo systems, are aimed at improving the efficiency and comfort of injection procedures, creating a niche market that addresses common pain points in medical and dental practices.

Additional Information

The company operates internationally, with a focus on the United States and China, and serves various medical fields including dentistry, plastic surgery, and dermatology. Incorporated in 1989 and based in Roseland, New Jersey, Milestone Scientific has established itself as a leader in innovative injection solutions.

Company Information

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

17

CEO

Mr. Jan Adriaan Haverhals

Country

United States

IPO Year

1995

Milestone Scientific Inc (MLSS) Latest News & Analysis

MLSS stock latest news image
Quick Summary

Dr. Ilana Etelzon has adopted the CompuFloยฎ Epidural System in her practice after a positive clinical experience, indicating potential growth opportunities for the product.

Why It Matters

The integration of the CompuFloยฎ Epidural System by Dr. Etelzon may signal growing clinical acceptance, potentially boosting sales and market confidence for the product's manufacturer.

Source: GlobeNewsWire
Market Sentiment: Neutral
MLSS stock latest news image
Quick Summary

Adoption of the CompuFloยฎ Epidural System is increasing, following a recent Medicare price assignment announcement.

Why It Matters

Expanding adoption of the CompuFloยฎ Epidural System suggests growing market acceptance, potentially increasing revenue for the company and impacting stock performance positively.

Source: GlobeNewsWire
Market Sentiment: Neutral
MLSS stock latest news image
Quick Summary

Milestone Scientific Inc. (NYSE: MLSS) will have CEO Arjan Haverhals and Chairman Neal Goldman presenting at The Benchmark Company's investor conference on December 11, 2024.

Why It Matters

The presentation at a prominent investor conference may enhance Milestone Scientific's visibility, potentially attracting new investment and affecting stock performance.

Source: GlobeNewsWire
Market Sentiment: Neutral
MLSS stock latest news image
Quick Summary

A new contract has been established, creating substantial market opportunities within federal healthcare systems.

Why It Matters

The contract indicates potential revenue growth for companies involved in federal healthcare, enhancing market confidence and driving stock valuations in related sectors.

Source: GlobeNewsWire
Market Sentiment: Neutral
MLSS stock latest news image
Quick Summary

Milestone Scientific Inc. (NYSE: MLSS) held its Q3 2024 earnings call on November 15, 2024, featuring CEO Arjan Haverhals and VP Finance Keisha Harcum.

Why It Matters

Milestone Scientific's Q3 earnings call reveals financial performance and strategic insights, impacting stock valuation and investor sentiment. Key executives will provide updates on growth and challenges.

Source: Seeking Alpha
Market Sentiment: Neutral
MLSS stock latest news image
Quick Summary

Milestone Scientific Inc. (NYSE: MLSS) reported a 57% increase in international dental sales for Q3 2024 and is expanding the CompuFloยฎ Epidural System rollout following Medicare pricing updates.

Why It Matters

A 57% rise in international dental sales and expansion of the CompuFloยฎ Epidural System signal strong growth potential and market demand for Milestone Scientific, positively impacting investor sentiment.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About MLSS Stock

What is Milestone Scientific Inc's (MLSS) stock forecast for 2025?

Based on our analysis of 1 Wall Street analysts, Milestone Scientific Inc (MLSS) has a median price target of $2.13. The highest price target is $3.00 and the lowest is $1.25.

Is MLSS stock a good investment in 2025?

According to current analyst ratings, MLSS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.24. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for MLSS stock?

Wall Street analysts predict MLSS stock could reach $2.13 in the next 12 months. This represents a 71.4% increase from the current price of $1.24. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Milestone Scientific Inc's business model?

Milestone Scientific Inc. generates revenue through the design, development, and commercialization of specialized medical devices and technologies, particularly in the dental and medical sectors. Its product offerings, such as the CompuDent and CompuFlo systems, are aimed at improving the efficiency and comfort of injection procedures, creating a niche market that addresses common pain points in medical and dental practices.

What is the highest forecasted price for MLSS Milestone Scientific Inc?

The highest price target for MLSS is $3.00 from at , which represents a 141.9% increase from the current price of $1.24.

What is the lowest forecasted price for MLSS Milestone Scientific Inc?

The lowest price target for MLSS is $1.25 from Bruce Jackson at Benchmark, which represents a 0.8% increase from the current price of $1.24.

What is the overall MLSS consensus from analysts for Milestone Scientific Inc?

The overall analyst consensus for MLSS is bullish. Out of 1 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.13.

How accurate are MLSS stock price projections?

Stock price projections, including those for Milestone Scientific Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.